Molecular Aspects of Viral Replication: HIV, HSV, and SARS-CoV-2

Molecular Aspects of Viral Replication

Overview of Viral Replication

Viral replication is a fundamental process in microbiology, involving the multiplication of viruses within host cells. Different virus types utilize distinct mechanisms and enzymes for replication, such as RNA-dependent RNA polymerase in RNA viruses and reverse transcriptase in retroviruses.

• RNA-dependent RNA polymerase: Enzyme used by single-stranded +RNA, single-stranded -RNA, and double-stranded RNA viruses for genome replication.

• Reverse transcriptase: Enzyme used by retroviruses to convert RNA genome into double-stranded DNA.

HIV: Human Immunodeficiency Virus

Classification and Structure

HIV is a retrovirus belonging to the lentivirus group, characterized by a complex genome and slow progression of infection. It causes AIDS and is transmitted through blood and sexual contact. HIV-1 and HIV-2 are the two major types, with HIV-1 being the most prevalent worldwide.

• Retrovirus: Virus that reverse-transcribes its RNA genome into DNA.

• Lentivirus: Subgroup of retroviruses with complex genomes and slow disease progression.

Origin and Evolution

HIV evolved from viruses infecting African monkeys. High mutation rates in infected patients generate multiple virus strains, forming a quasispecies—a dynamic population of diverse mutants with varying replication, tissue tropism, and drug resistance.

HIV Genome and Accessory Proteins

The HIV genome encodes structural proteins, enzymes, and accessory proteins that regulate viral replication and immune evasion.

• Structural proteins: Matrix (MA), Capsid (CA), Nucleocapsid (NC)

• Enzymes: Reverse transcriptase (RT), Integrase (IN), Protease (PR)

• Accessory proteins: Vif, Vpr, Nef, Vpu, Rev, Tat

Protein	Function	Effect of Mutation
Vif	Protects reverse transcriptase from host restriction	Virions produced are noninfective
Vpr	Activates HIV transcription, imports DNA into nucleus	Lower production of virions
Nef	Downregulates CD4, evades immune response	Slower progression to AIDS
Vpu	Degrades CD4, releases virions	Early death of host cell, lower production of virions
Rev	Stabilizes mRNA, exports viral proteins	Failure of infection
Tat	Activates transcription	Failure of chromosome replication

HIV Structure: SU-TM Trimer Complex

The HIV envelope contains the SU (gp120) and TM (gp41) proteins, forming a trimer complex essential for host cell attachment and membrane fusion.

Attachment and Entry into Host Cells

HIV attaches to host cells via the CD4 receptor and CCR5 co-receptor. The gp120 protein binds to CD4, triggering conformational changes that allow gp41 to mediate membrane fusion. Entry inhibitors, such as Maraviroc, block CCR5 binding.

Replication Cycle of HIV

The HIV replication cycle involves several steps:

1. Attachment to CD4+ T cells

2. Fusion of viral and host membranes

3. Reverse transcription of RNA genome into DNA

4. Integration of viral DNA into host genome

5. Transcription and translation of viral proteins

6. Assembly and release of new virions

HIV Drug Actions

• Nucleoside reverse transcriptase inhibitors: Block reverse transcription (e.g., AZT)

• Non-nucleoside reverse transcriptase inhibitors: Inhibit reverse transcriptase by binding to enzyme

• Protease inhibitors: Prevent maturation of viral proteins

• Fusion inhibitors: Block fusion of viral and host membranes

• Entry inhibitors: Block CCR5 co-receptor

• Integrase inhibitors: Prevent integration of viral DNA into host genome

Herpes Simplex Virus (HSV)

Classification and Structure

Herpes Simplex Virus (HSV) is a DNA virus with two main strains: HSV-1 (oral lesions) and HSV-2 (genital lesions). Primary infection occurs in epithelial cells, but latent infection can persist in neurons.

• HSV-1: Mainly causes oral lesions

• HSV-2: Mainly causes genital lesions

Attachment and Entry

HSV virions use envelope proteins to bind to host cell receptors. Microtubular scaffolds transport virions to the nucleus, where the DNA circularizes for transcription.

Replication Cycle of HSV

• Attachment and entry into epithelial cells

• Transport to nucleus and circularization of DNA

• Transcription of mRNA for infection cycle or latency

• Rolling-circle replication of DNA genome

• Production of capsid, matrix, and envelope proteins

• Assembly at membrane and release by exocytosis

Persistent Viral Infections

Herpes viruses can establish latency, allowing indefinite infection. Maintenance of latency involves:

• Infection of cell types suitable for persistence

• Regulation of viral gene expression

• Subversion of apoptosis

• Evasion of immune responses

SARS-CoV-2: Coronavirus

Replication Cycle

SARS-CoV-2 is a single-stranded RNA virus responsible for COVID-19. Its replication cycle involves entry via endocytosis or membrane fusion, translation of viral proteins, replication of RNA genome, assembly, and release of new virions.

Summary Table: Comparison of HIV, HSV, and SARS-CoV-2

Virus	Genome Type	Replication Enzyme	Latency	Drug Targets
HIV	ssRNA (retrovirus)	Reverse transcriptase	Yes (integrated DNA)	RT, protease, integrase, entry/fusion
HSV	dsDNA	DNA polymerase	Yes (neurons)	DNA polymerase, entry
SARS-CoV-2	ssRNA (+)	RNA-dependent RNA polymerase	No	RNA polymerase, entry

Key Equations

• Reverse Transcription (HIV): $\text{RNA} \xrightarrow{\text{Reverse Transcriptase}} \text{cDNA} \xrightarrow{\text{Integrase}} \text{Integrated DNA}$

• Rolling-Circle Replication (HSV): $\text{Circular DNA} \xrightarrow{\text{DNA Polymerase}} \text{Concatemeric DNA}$

• RNA Replication (SARS-CoV-2): $\text{ssRNA (+)} \xrightarrow{\text{RNA-dependent RNA Polymerase}} \text{ssRNA (-)} \xrightarrow{\text{RNA-dependent RNA Polymerase}} \text{ssRNA (+)}$

Additional info:

• Highly active antiretroviral therapy (HAART) combines multiple drug classes to suppress HIV replication.

• Herpes viruses can cause a range of diseases, including chickenpox, mononucleosis, and Kaposi's sarcoma.

• SARS-CoV-2 replication involves both cytoplasmic and membrane-associated steps, with unique mechanisms for RNA synthesis and protein translation.